Baixar PDF

Outros usuários também visualizaram estes artigos

LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY E Crusoe; T Facon; P Moreau; I Spicka; K Suzuki; K Yong; J Mikhael; T Fukao; N Armstrong; T Martin;
Hematol Transfus Cell Ther. 2023;45 Supl 4:S400
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS A Maiolino; R Hajek; T Jelinek; P Moreau; T Martin; L Pour; G Mikala; A Symeonidis; S Bringhen; A Rawlings; ML Risse; H Vande-Velde; I Spicka;
Hematol Transfus Cell Ther. 2021;43 Supl 1:S197-8
ERUPÇÃO VARICELIFORME DE KAPOSI EM PACIENTE COM LLA EM TRATAMENTO SEM PROFILAXIA VIRAL: UM RELATO DE CASO LF Negri; A Fenili; F Moreno; AP Gouvea; S Vidor; M Capra; T Brum; LCG Trindade; MO Ughini; DB Lamaison;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S412